Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 1369–1404
- Headlines
- 5511
- Sources here
- 14
- Companies here
- 32
Chronological news
Earlier headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
IRadimed (IRMD) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Friday, July 31, 2026 at 11:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Roger SusiChief Financial Officer - John Glenn TAKEAWAYS Revenue -- $20.5 million, representing a 0.5% increase from $20.4 million in the second …
Enovis (ENOV) Stock Eyes Margin Gains as Free Cash Flow Improves
Enovis (ENOV) stock saw a modest 1.1% increase despite reporting significant improvements in its Q2 financials, including a narrowed net loss, improved gross and EBITDA margins, and positive free cash flow of US$31 million. The company's future prospects hinge on translating operational progress into …
Integer Holdings Corp (ITGR) Stock News Today
This article provides recent stock news for Integer Holdings Corp (ITGR), including its current stock price and market capitalization. It highlights related news such as Stryker Corp (SYK) and Intuitive Surgical Inc (ISRG) stock movements on August 3rd. The page also features an overview …
Apyx Medical Corp (APYX) Stock News Today
This page provides an overview of Apyx Medical Corp (APYX) stock information, including its current trading price, market cap, and links to news, analysis, financials, and other company data. It notes that more earnings news will be coming soon for the company.
Apyx Medical (NASDAQ:APYX) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS
Apyx Medical (NASDAQ:APYX) reported its quarterly earnings, beating analyst expectations with an adjusted loss of $0.07 per share against a projected $0.08 loss and revenue of $13.88 million. This revenue marked a 22% increase year-over-year, driven by a significant rise in surgical aesthetics sales …
Orthofix Medical Inc. (OFIX): Analyzing the 34.43% Potential Upside in the Medical Devices Sector
Orthofix Medical Inc. (NASDAQ: OFIX) is a medical devices company with a projected 34.43% potential upside, according to analyst consensus. Despite financial challenges like negative EPS and ROE, the company is seen as undergoing a transformation with strategic investments in product development, particularly in …
STERIS plc (Ireland) (STE) Stock Forecasts
STERIS plc (STE) is a medical technology company specializing in sterilization services and infection prevention, holding a leading position in contract sterilization. A recent Morningstar report highlights the company's healthy fundamentals, which are enabling accelerated share repurchases and increased investment. The report provides a …
Medtronic (MDT) Wins Expanded CE Mark For Affera System In Ventricular Arrhythmias
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Medtronic (NYSE:MDT) receives expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for ventricular arrhythmia treatment. The Sphere-9 catheter …
Piper Sandler cuts CVRx stock rating on sales, reimbursement issues
Piper Sandler downgraded CVRx Inc (NASDAQ:CVRX) to Neutral from Overweight and lowered its price target to $4.00 from $12.00, citing sales force issues and challenges in obtaining consistent reimbursement from its largest payer. While CVRx's second-quarter revenue surpassed estimates, the company reduced its full-year …
Insider Selling: Alphatec (NASDAQ:ATEC) General Counsel Sells 8,168 Shares
Alphatec (NASDAQ:ATEC) General Counsel Tyson Eliot Marshall sold 8,168 shares of the company's stock, valued at $78,821.20, on August 5th. This transaction was part of a pre-arranged Rule 10b5-1 plan to cover tax withholding obligations from vested equity awards. Despite this insider sale, Alphatec …
CVRx (CVRX) Stock Reels From Guidance Cut And Cash Burn Fears
CVRx (CVRX) stock dropped almost 60% after cutting its 2026 revenue guidance to US$58m-US$60m and providing softer Q3 guidance. Despite strong Q2 revenue of US$15.7m and high gross margins of 87%, the company reported a US$14.0m net loss and continues to burn cash, raising …
Alamar Biosciences, Inc. - Class A common stock (Nasdaq:ALMR) Stock Quote
This page provides a stock quote for Alamar Biosciences, Inc. (Nasdaq: ALMR), showing its current trading price, daily performance, and key financial metrics like volume and trading ranges. It also lists recent news, including Q2 2026 earnings, partnership announcements, and new product launches, highlighting …
A Look at Glaukos Corp (GKOS) After 5.3% Gain -- GF Value $147.7
Glaukos Corp (GKOS) recently saw a 5.3% stock gain, closing at $180.02, but GuruFocus assesses it as 21.8% overvalued with a GF Value of $147.78. Despite a strong GF Score™ of 78/100 and high growth potential (9/10), the company faces significant challenges with low …
Brainsway Ltd (BWAY) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Brainsway Ltd (BWAY), highlighting its strong earnings forecast score and analyst ratings. The average price target for BWAY is $23.50, with analysts largely recommending a "Strong Buy." The report also details past and projected EPS and revenue …
Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates
Conmed Corp (CNMD) has an earnings forecast score of 5.71, ranking 183 out of 200 in its industry, with an average analyst price target of $52.00. Analysts currently recommend a "Hold" rating for the stock. The company's expected revenue for the next quarter is …
Cerus Corp (CERS) Stock News Today
This page provides the latest news and information for Cerus Corp (CERS) stock on TradingKey, a financial information platform. As of August 7th, Cerus Corp's stock closed at $2.350, up 1.29%. The platform also offers an overview, news and analysis, financial data, stock score, …
Trinity Biotech PLC (TRIB) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Trinity Biotech PLC (TRIB), focusing on future EPS and revenue growth estimates. It includes current stock information, market cap, and a comparison with peer companies in the healthcare equipment sector. The data presented was last updated on …
Price to earnings forward of TriSalus Life Sciences, Inc. – NASDAQ:TLSIW
This page provides financial information for TriSalus Life Sciences, Inc. (NASDAQ: TLSIW), focusing on its price-to-earnings forward ratio. The content indicates that the market was closed with no trades at the time of viewing, and includes copyright information from FactSet, American Bankers Association, and …
Osisko Metals (TSX:OM) Is Up 20.8% After Reporting Deepening 2026 Losses Has The Bull Case Changed?
Osisko Metals Incorporated reported second-quarter 2026 results showing a net loss of C$84.13 million, versus net income of C$0.796 million in the same period a year earlier, with basic and diluted loss per share from continuing operations of C$0.11. Over the first six months …
Tandem Diabetes Care, Inc. Stock 12‑Month Price Target Raised to $29.5, Implies 57% Upside
Analysts have raised the average 12-month price target for Tandem Diabetes Care, Inc. (TNDM) stock to $29.5, up from $29.19. This new target suggests a potential upside of approximately 57% from its August 6th closing price. The consensus rating among 22 analysts remains a …
Beta Bionics (NASDAQ:BBNX) Shares Up 13.7% - Should You Buy?
Beta Bionics (NASDAQ:BBNX) saw its shares surge by 13.7% to $16.05, trading above its 50-day and 200-day moving averages, though its high beta of 3.13 indicates significant volatility. Analysts hold a "Moderate Buy" consensus with a $20.10 price target, despite one firm issuing a …
Avanos Medical Inc (AVNS) Earnings Forecast: Future EPS & Revenue Growth Estimates
Avanos Medical Inc (AVNS) has an earnings forecast score of 6.00, placing it 174th in the Healthcare Equipment & Supplies industry. Analysts have set a target price of $14.00 for AVNS, with one analyst recommending a "Hold" rating. The company's expected revenue for the …
Accuray Transfers Listing to Nasdaq Capital Market
Accuray (ARAY) has received Nasdaq approval to transfer its common stock listing from the Nasdaq Global Select Market to the Nasdaq Capital Market, effective August 6, 2026. This transfer grants the company an additional 180 days, until February 1, 2027, to meet Nasdaq's minimum …
PODD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (PO
Faruqi & Faruqi, LLP is reminding investors of the August 31, 2026 deadline to seek lead plaintiff status in a federal securities class action lawsuit against Insulet Corporation (NASDAQ: PODD). The lawsuit alleges that Insulet made false and misleading statements about defective manufacturing controls …
PODD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026
Faruqi & Faruqi, LLP is investigating potential claims against Insulet Corporation (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit. The lawsuit alleges Insulet made false and/or misleading …
Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS
Treace Medical Concepts (NASDAQ:TMCI) announced its quarterly earnings, reporting an adjusted loss of $0.24 per share, surpassing the consensus estimate of a $0.30 loss, with revenues of $45.38 million beating the $44.02 million forecast. The company raised its 2026 revenue guidance to $204 million–$212 …
Penumbra Inc (PEN) Stock News Today
This article provides current stock information for Penumbra Inc (PEN), including its latest stock price, market capitalization, and P/E ratio. It notes that this page will feature news, earnings, analyst ratings, and key developments related to PEN stock, with more updates expected soon. The …
AdaptHealth Corp. Just Missed Earnings; Here's What Analysts Are Forecasting Now
AdaptHealth Corp. (NASDAQ:AHCO) shares plunged 43% after missing Q2 earnings estimates, with revenues falling 13% short and the company reporting a statutory loss instead of a forecasted profit. Analysts have significantly cut revenue forecasts and now anticipate a loss for 2026, leading to a …
Canaccord raises Artivion stock price target on acquisition, PMA approval
Canaccord raised its price target for Artivion Inc. (NYSE:AORT) to $39 from $36, maintaining a Buy rating, following the company's acquisition of Endospan and PMA approval for AMDS. Artivion's second-quarter revenue of $125.8 million and adjusted EBITDA of $26.4 million both surpassed analyst estimates, …
Avior Wealth Management LLC Lowers Stake in Abbott Laboratories $ABT
Avior Wealth Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT) by 47.5% in the second quarter, selling 19,199 shares and retaining 21,257 shares valued at $1.93 million. Despite this, analysts maintain a "Moderate Buy" rating for Abbott with an average price target of …